Verition Fund Management’s Medicines Co MDCO Stock Holding History

Verition Fund Management’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-61,929	Closed	-$5.26M	–	1229
2019 Q4	$5.26M	Buy	+61,929	New	+$4.13M	0.1%	145
2019 Q1	–	Sell	-28,761	Closed	-$550K	–	1400
2018 Q4	$550K	Buy	+28,761	New	+$669K	0.04%	430
2018 Q3	–	Sell	-8,778	Closed	-$322K	–	1523
2018 Q2	$322K	Buy	+8,778	New	+$285K	0.02%	830
2018 Q1	–	Sell	-13,681	Closed	-$374K	–	1378
2017 Q4	$374K	Buy	+13,681	New	+$421K	0.03%	590
2017 Q1	–	Sell	-8,188	Closed	-$278K	–	1570
2016 Q4	$278K	Buy	+8,188	New	+$290K	0.02%	870

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Verition Fund Management's MDCO Position: Q1 2020 in Review

Verition Fund Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 61,929 shares — an estimated $5.26M sold.

Verition Fund Management first reported a position in MDCO in Q4 2016 and held it in 5 quarters. The position peaked at $5.26M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Verition Fund Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Verition Fund Management sold 61,929 Medicines Co shares in Q1 2020, an estimated $5.26M.
Verition Fund Management first reported a position in Medicines Co in Q4 2016 and held it in 5 quarters.
Verition Fund Management's Medicines Co position peaked at $5.26M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Verition Fund Management's 13F filing for Q1 2020, filed 15 May 2020.